Alım fiyatı
25,33
25,33
25,32
233.06 B
Geçmiş performansa ilişkin bilgiler gelecekteki performansın güvenilir bir göstergesi değildir.
The company's stock has under-performed its sector so far in 2024, while the company managed to beat EPS consensus estimates during the last quarter results. Meanwhile, Pfizer has been increasing its dividend consistently year-over-year for the last 7 years, becoming an attractive stock for dividend income-oriented investors. Additionally, Pfizer has a strong product pipeline that could potentially produce additional revenue streams in the future. Going forward, competition from generic drugs and pricing pressures remain the company's most important headwinds.
Bir hesap oluşturun ve hızlı bir doğrulama işlemini tamamlayın.
Kart, banka havalesi veya kripto yoluyla cüzdanınıza para ekleyin.
PFE seçin, miktarı ayarlayın ve al ya da sat seçeneğine tıklayın - işte bu kadar!
Pfizer Inc.
PFE
25,325
+0.68%
SSS